Physician profile
Gregory Thompson
NPI 1083093652
$5,248.89
in general payments reported to CMS, 2019-2025
39 companies · $920 in 2025
The $920 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $428 · 2021: $448 · 2022: $1,546 · 2023: $904 · 2024: $780 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,504.56 | 2021-2024 | Phasix Mesh |
| Paratek Pharmaceuticals, INC. | $633.02 | 2022-2025 | Nuzyra |
| C. R. Bard, INC. & Subsidiaries | $414.78 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $348.88 | 2022-2023 | Vibativ |
| Abbvie INC. | $282.61 | 2022-2025 | Dalvance, Teflaro |
| Smith+Nephew, INC. | $157.03 | 2022-2025 | Renasys Go V2 Home |
| Baxter Healthcare | $153.89 | 2021-2024 | Perclot |
| Solventum Corporation | $141.20 | 2024-2025 | Activ.A.C., 3m Cavilon, V.A.C. Veraflo |
| Urgo Medical North America, LLC | $126.28 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Urgok2 |
| Pacira Pharmaceuticals Incorporated | $122.55 | 2025 | Exparel |
| Boston Scientific Corporation | $118.12 | 2019 | |
| Intuitive Surgical, INC. | $116.41 | 2023 | |
| Organogenesis INC. | $105.38 | 2023 | Puraply |
| Conmed Corporation | $104.88 | 2019 | |
| Novo Nordisk INC | $103.31 | 2022-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $92.58 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $68.38 | 2023-2024 | Interstim, Signia |
| Lifenet Health | $65.02 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $62.87 | 2025 | |
| Polynovo North America LLC | $56.03 | 2022 | |
| Ethicon US, LLC | $43.15 | 2024-2025 | Proximate, Echelon; Endopath, Echelon Endopath |
| Myriad Genetic Laboratories, INC. | $42.97 | 2022-2024 | Myrisk |
| Siemens Medical Solutions USA, INC. | $39.29 | 2023 | Varian Cryocare Touch System |
| E.R. Squibb & Sons, L.L.C. | $38.85 | 2020-2023 | |
| Integra Lifesciences Corporation | $33.01 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Hydrofera LLC | $28.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.61 | 2025 | Gattex |
| Braintree Laboratories, INC. | $26.56 | 2022 | |
| Endogastric Solutions, INC | $21.35 | 2024 | Esophyx |
| Incyte Corporation | $20.14 | 2025 | Jakafi |
| Northgate Technologies, INC. | $19.51 | 2023 | Nti Branded Other (Nti) |
| Kci USA, INC. | $19.13 | 2023 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Promogran Prisma |
| Bioventus LLC | $18.95 | 2022 | |
| Hartmann USA, INC. | $17.77 | 2022 | |
| Horizon Therapeutics Plc | $17.65 | 2023 | Krystexxa |
| Tactile Systems Technology INC | $15.27 | 2025 | Nimbl, Flexitouch Plus |
| Hologic Sales and Service, LLC | $13.70 | 2023 | Coolseal Generator |
| Mimedx Group, INC. | $13.47 | 2025 | |
| Lemaitre Vascular, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.